These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 26045281

  • 1. Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
    Kohli R, Myronovych A, Tan BK, Salazar-Gonzalez RM, Miles L, Zhang W, Oehrle M, Sandoval DA, Ryan KK, Seeley RJ, Setchell KD.
    Dig Dis; 2015; 33(3):440-6. PubMed ID: 26045281
    [Abstract] [Full Text] [Related]

  • 2. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.
    Browning MG, Pessoa BM, Khoraki J, Campos GM.
    Curr Obes Rep; 2019 Jun; 8(2):175-184. PubMed ID: 30847736
    [Abstract] [Full Text] [Related]

  • 3. Treatment of NASH with Gastric Bypass.
    Jirapinyo P, Thompson CC.
    Curr Gastroenterol Rep; 2018 Sep 22; 20(10):49. PubMed ID: 30244334
    [Abstract] [Full Text] [Related]

  • 4. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V, Vajro P, Dezsofi A, Fischler B, Hadzic N, Jahnel J, Lamireau T, McKiernan P, McLin V, Socha P, Tizzard S, Baumann U.
    J Pediatr Gastroenterol Nutr; 2015 Apr 22; 60(4):550-61. PubMed ID: 25591123
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Klebanoff MJ, Corey KE, Samur S, Choi JG, Kaplan LM, Chhatwal J, Hur C.
    JAMA Netw Open; 2019 Feb 01; 2(2):e190047. PubMed ID: 30794300
    [Abstract] [Full Text] [Related]

  • 6. Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery.
    Bozadjieva N, Heppner KM, Seeley RJ.
    Diabetes; 2018 Sep 01; 67(9):1720-1728. PubMed ID: 30135133
    [Abstract] [Full Text] [Related]

  • 7. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L, Li M, Zeng N, Liu Y, Bai R, Zhang N, Song J, Zhang P, Yao Q, Yang Z, Zhao X, Zhang Y, Zhang P, Zhang Z.
    BMC Surg; 2021 Jun 24; 21(1):298. PubMed ID: 34167531
    [Abstract] [Full Text] [Related]

  • 8. Bile acids and bariatric surgery.
    Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR.
    Mol Aspects Med; 2017 Aug 24; 56():75-89. PubMed ID: 28390813
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.
    Kumar S, Khandelwal N, Kumar A, Yadav K, Sharma S, Sable S, Chauhan A, Kapoor S, Varma V, Palep J, Kumaran V.
    Indian J Gastroenterol; 2017 May 24; 36(3):243-247. PubMed ID: 28560633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.
    Liu H, Hu C, Zhang X, Jia W.
    J Diabetes Investig; 2018 Jan 24; 9(1):13-20. PubMed ID: 28434196
    [Abstract] [Full Text] [Related]

  • 13. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A, Al-Kurd A, Wilson R, Bena J, Fayazzadeh H, Singh T, Albaugh VL, Shariff FU, Rodriguez NA, Jin J, Brethauer SA, Dasarathy S, Alkhouri N, Schauer PR, McCullough AJ, Nissen SE.
    JAMA; 2021 Nov 23; 326(20):2031-2042. PubMed ID: 34762106
    [Abstract] [Full Text] [Related]

  • 14. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, Raverdy V, Leteurtre E, Dharancy S, Louvet A, Romon M, Duhamel A, Pattou F, Mathurin P.
    Gastroenterology; 2015 Aug 23; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [Abstract] [Full Text] [Related]

  • 15. Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries.
    Wei M, Shao Y, Liu QR, Wu QZ, Zhang X, Zhong MW, Liu SZ, Zhang GY, Hu SY.
    Am J Physiol Gastrointest Liver Physiol; 2018 May 01; 314(5):G537-G546. PubMed ID: 29351394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.
    Tsuchiya T, Naitoh T, Nagao M, Tanaka N, Watanabe K, Imoto H, Miyachi T, Motoi F, Unno M.
    Obes Surg; 2018 Jun 01; 28(6):1643-1652. PubMed ID: 29235014
    [Abstract] [Full Text] [Related]

  • 19. The Influence of Bariatric Surgery on Serum Bile Acids in Humans and Potential Metabolic and Hormonal Implications: a Systematic Review.
    Cole AJ, Teigen LM, Jahansouz C, Earthman CP, Sibley SD.
    Curr Obes Rep; 2015 Dec 01; 4(4):441-50. PubMed ID: 26335653
    [Abstract] [Full Text] [Related]

  • 20. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Shouhed D, Steggerda J, Burch M, Noureddin M.
    Expert Rev Gastroenterol Hepatol; 2017 Sep 01; 11(9):797-811. PubMed ID: 28712339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.